湖(hu)南華納(na)大藥(yao)廠股份有限公(gong)(gong)司(si)2001年創立,注冊資本7030萬元。公(gong)(gong)司(si)秉持“科技(ji)服務健(jian)康”的企業(ye)宗(zong)旨,遵循“潛心(xin)制藥(yao)、誠信待人(ren)”的企業(ye)經營理念,堅(jian)持走專業(ye)化的發展道路(lu),以質量為保(bao)障、以服務為依托,努力把公(gong)(gong)司(si)打(da)造成(cheng)“一(yi)個值(zhi)得信賴的健(jian)康產品供(gong)應商”。
湖南(nan)(nan)華納大藥(yao)(yao)廠股(gu)份有限(xian)公(gong)司(si)(si)聯合本土中南(nan)(nan)大學(xue)、湖南(nan)(nan)中醫(yi)藥(yao)(yao)大學(xue)等(deng)機(ji)構(gou)打造(zao)了(le)湖南(nan)(nan)省(sheng)手性藥(yao)(yao)物工程研(yan)(yan)究(jiu)中心、湖南(nan)(nan)省(sheng)中藥(yao)(yao)配(pei)方(fang)顆粒工程研(yan)(yan)究(jiu)中心兩個研(yan)(yan)發平(ping)臺(tai),分別拓展(zhan)公(gong)司(si)(si)未來(lai)(lai)在化學(xue)制(zhi)藥(yao)(yao)領(ling)(ling)域和(he)中藥(yao)(yao)與天(tian)然藥(yao)(yao)物領(ling)(ling)域的生存(cun)空間:在化學(xue)藥(yao)(yao)物領(ling)(ling)域,以(yi)成梯次(ci)和(he)成系列的產品(pin)組合為主線,持續(xu)開展(zhan)仿(fang)制(zhi)藥(yao)(yao)領(ling)(ling)域的緩、控釋制(zhi)劑(ji)和(he)小容量注射劑(ji)、凍干粉針(zhen)劑(ji)產品(pin)的研(yan)(yan)發,提(ti)升化藥(yao)(yao)仿(fang)制(zhi)藥(yao)(yao)研(yan)(yan)發能力(li),并進(jin)(jin)(jin)一步保障公(gong)司(si)(si)未來(lai)(lai)的可持續(xu)成長能力(li)。同時(shi),通過研(yan)(yan)發外(wai)包、合作、引(yin)進(jin)(jin)(jin)等(deng)方(fang)式(shi),布局原創化學(xue)新(xin)藥(yao)(yao)研(yan)(yan)發,促進(jin)(jin)(jin)企業創新(xin)的轉型升級。
在中(zhong)(zhong)藥(yao)(yao)領域,以現代中(zhong)(zhong)藥(yao)(yao)為指引,持續開(kai)展(zhan)中(zhong)(zhong)藥(yao)(yao)顆粒飲(yin)片、中(zhong)(zhong)藥(yao)(yao)新藥(yao)(yao)、植提(ti)原料的研發,同時,開(kai)展(zhan)植提(ti)原料的國際注冊,做(zuo)大做(zuo)強中(zhong)(zhong)藥(yao)(yao)產業。
湖南(nan)(nan)(nan)華(hua)(hua)納(na)(na)大(da)(da)(da)藥(yao)(yao)(yao)廠(chang)(chang)股(gu)份有(you)(you)限(xian)(xian)公(gong)(gong)司(si)規劃(hua)三個生(sheng)產(chan)(chan)(chan)(chan)基地:湖南(nan)(nan)(nan)華(hua)(hua)納(na)(na)大(da)(da)(da)藥(yao)(yao)(yao)廠(chang)(chang)(化(hua)(hua)藥(yao)(yao)(yao)制(zhi)劑生(sheng)產(chan)(chan)(chan)(chan)基地,湖南(nan)(nan)(nan)瀏陽(yang)經(jing)(jing)開區(qu))、湖南(nan)(nan)(nan)華(hua)(hua)納(na)(na)大(da)(da)(da)藥(yao)(yao)(yao)廠(chang)(chang)天(tian)然藥(yao)(yao)(yao)物(wu)有(you)(you)限(xian)(xian)公(gong)(gong)司(si)(中(zhong)(zhong)藥(yao)(yao)(yao)生(sheng)產(chan)(chan)(chan)(chan)基地,湖南(nan)(nan)(nan)瀏陽(yang)經(jing)(jing)開區(qu))、湖南(nan)(nan)(nan)華(hua)(hua)納(na)(na)大(da)(da)(da)藥(yao)(yao)(yao)廠(chang)(chang)手(shou)性藥(yao)(yao)(yao)物(wu)有(you)(you)限(xian)(xian)公(gong)(gong)司(si)(化(hua)(hua)藥(yao)(yao)(yao)原料生(sheng)產(chan)(chan)(chan)(chan)基地,湖南(nan)(nan)(nan)望城銅(tong)官循環經(jing)(jing)濟園區(qu)),初步形(xing)成了配套(tao)良好的(de)(de)從化(hua)(hua)學(xue)原料藥(yao)(yao)(yao)到(dao)化(hua)(hua)學(xue)藥(yao)(yao)(yao)物(wu)制(zhi)劑、從中(zhong)(zhong)藥(yao)(yao)(yao)資(zi)源到(dao)中(zhong)(zhong)成藥(yao)(yao)(yao)與植(zhi)物(wu)提(ti)(ti)取物(wu)的(de)(de)完整產(chan)(chan)(chan)(chan)業(ye)鏈(lian),生(sheng)產(chan)(chan)(chan)(chan)平臺的(de)(de)專(zhuan)業(ye)化(hua)(hua)、規模化(hua)(hua)、自動化(hua)(hua)水平持續提(ti)(ti)升,生(sheng)產(chan)(chan)(chan)(chan)成本有(you)(you)效(xiao)降低,進而為產(chan)(chan)(chan)(chan)品(pin)市場競爭力與產(chan)(chan)(chan)(chan)品(pin)市場占有(you)(you)率的(de)(de)提(ti)(ti)升創造有(you)(you)利條件。
湖南(nan)華納大(da)藥(yao)廠股份有(you)限公司(si)在國內(nei)分(fen)(fen)區(qu)域(yu)(yu)組建辦事處(chu),展開(kai)對(dui)區(qu)域(yu)(yu)內(nei)醫療(liao)機構的學術推(tui)廣、以(yi)及(ji)對(dui)OTC終端(duan)(duan)的市場(chang)宣傳,擴大(da)制劑銷(xiao)售團(tuan)隊對(dui)終端(duan)(duan)的推(tui)廣能力,推(tui)動單品(pin)(pin)(pin)銷(xiao)售規模(mo)(mo)上(shang)臺階,實現銷(xiao)售人(ren)員規模(mo)(mo)、單品(pin)(pin)(pin)規模(mo)(mo)的同步成長。制劑產品(pin)(pin)(pin)多庫酯(zhi)鈉片(pian)(pian)、膠(jiao)體果膠(jiao)鉍干混懸(xuan)劑、磷霉素(su)氨(an)丁三醇散(san)、法羅培南(nan)鈉顆(ke)粒、雙氯芬酸鈉緩釋片(pian)(pian)、銀杏葉分(fen)(fen)散(san)片(pian)(pian)、裸花紫珠分(fen)(fen)散(san)片(pian)(pian)、金雞分(fen)(fen)散(san)片(pian)(pian)、人(ren)參蜂王(wang)漿(jiang)咀嚼片(pian)(pian)等,及(ji)原料(liao)藥(yao)膠(jiao)體果膠(jiao)鉍、泮托(tuo)拉(la)唑鈉、磷霉素(su)氨(an)丁三醇、法羅培南(nan)鈉等品(pin)(pin)(pin)種規模(mo)(mo)與(yu)品(pin)(pin)(pin)牌不斷提升。